FAES FARMA S.A. informs of the approval of bilastine in Mexico and hidrosmine in Venezuela.

The Mexican Health authorities have approved bilastine, under PFIZER's name, the leading pharmaceutical company in the world and in Mexico.
The next step will be bilastine's commercialization by Pfizer, with
FAES FARMA as the manufacturer.
Mexico is Latin America's second biggest pharmaceutical market. On the other hand, FAES FARMA has obtained the approval of its
venotonic hidrosmine in Venezuela, South America's third biggest market. This is the first of the product line that FAES FARMA will market under its own brand in that country.
Both news are very positive and represent a major advance in the progress of FAES FARMA's project in Latin America.
2nd July 2012

1

distributed by